Antimicrobial resistance and virulence factors of Klebsiella pneumoniae affecting 30 day mortality in patients with bloodstream infection

被引:54
作者
Kim, Dokyun [1 ,2 ]
Park, Byeol Yi [1 ,2 ]
Choi, Min Hyuk [1 ,2 ]
Yoon, Eun-Jeong [1 ,2 ]
Lee, Hyukmin [1 ,2 ]
Lee, Kwang Jun [3 ]
Park, Yoon Soo [4 ]
Shin, Jong Hee [5 ]
Uh, Young [6 ]
Shin, Kyeong Seob [7 ]
Shin, Jeong Hwan [8 ,9 ]
Kim, Young Ah [10 ]
Jeong, Seok Hoon [1 ,2 ]
机构
[1] Yonsei Univ, Coll Med, Dept Lab Med, Seoul, South Korea
[2] Yonsei Univ, Coll Med, Res Inst Bacterial Resistance, Seoul, South Korea
[3] Ctr Dis Control & Prevent, Natl Inst Hlth, Div Antimicrobial Resistance, Cheongju, South Korea
[4] Ilsan Hosp, Natl Hlth Insurance Serv, Dept Internal Med, Div Infect Dis, Goyang, South Korea
[5] Chonnam Natl Univ, Sch Med, Dept Lab Med, Gwangju, South Korea
[6] Yonsei Univ, Wonju Coll Med, Dept Lab Med, Wonju, South Korea
[7] Chungbuk Natl Univ, Coll Med, Dept Lab Med, Cheongju, South Korea
[8] Inje Univ, Coll Med, Dept Lab Med, Busan, South Korea
[9] Inje Univ, Coll Med, Palk Inst Clin Res, Busan, South Korea
[10] Ilsan Hosp, Natl Hlth Insurance Serv, Dept Lab Med, Goyang, South Korea
关键词
BACTEREMIA; OUTCOMES;
D O I
10.1093/jac/dky397
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: To investigate the risk factors of patients with Klebsiella pneumoniae (KP) bloodstream infection (BSI) with a focus on antimicrobial resistance and virulence factors. Methods: All KP BSI patients (n = 579) from six general hospitals during a 1 year period were included in this study. The risk factors of hosts and causative KP isolates were assessed to determine associations with the 30 day mortality of KP BSI patients by multivariate Cox hazards modelling. Results: The 30 day mortality rate of KP BSI patients was 16.9% (98/579). Among the host-associated factors, increased SOFA score and leucopenia status exhibited strong associations with increased 30 day mortality. Among the pathogenic factors, carriage of the pks gene cluster (adjusted HR 1.80; 95% CI 1.16-2.79) was a risk factor, especially when accompanied by MDR. In this regard, KP isolates of the wzi50 capsular type (n = 22) frequently harboured pks (63.6%, 14/22) and ybtA (68.2%, n = 15) and mostly exhibited MDR (63.6%, n = 14), resulting in increased 30 day mortality. In contrast, hypermucoviscous KP isolates showed an inverse association with 30 day mortality (adjusted HR 0.55; 95% CI 0.33-0.90). Conclusions: Despite the reported virulence of hypermucoviscous KP strains, they were associated with good prognoses in KP BSI patients. Importantly, carriage of the pks gene cluster, which is responsible for the synthesis of colibactin, was a relevant marker of early mortality.
引用
收藏
页码:190 / 199
页数:10
相关论文
共 50 条
  • [21] High mortality and antimicrobial resistance of Klebsiella pneumoniae bacteremia in northern Taiwan
    Chen, Chyi-Liang
    Hou, Pin-Chun
    Wang, Yun-Ting
    Lee, Hao-Yuan
    Zhou, Ying-Li
    Wu, Ting-Shu
    Janapatla, Rajendra-Prasad
    Yang, Chien-Chang
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2020, 14 (04): : 373 - 379
  • [22] Risk Factors for 30-Day Mortality in Nosocomial Enterococcal Bloodstream Infections
    Zerbato, Verena
    Pol, Riccardo
    Sanson, Gianfranco
    Suru, Daniel Alexandru
    Pin, Eugenio
    Tabolli, Vanessa
    Monticelli, Jacopo
    Busetti, Marina
    Toc, Dan Alexandru
    Croce, Lory Saveria
    Luzzati, Roberto
    Di Bella, Stefano
    ANTIBIOTICS-BASEL, 2024, 13 (07):
  • [23] Bloodstream infections caused by Klebsiella pneumoniae: prevalence of blaKPC, virulence factors and their impacts on clinical outcome
    Xu, Min
    Fu, Yiqi
    Kong, Haishen
    Chen, Xiao
    Chen, Yu
    Li, Lanjuan
    Yang, Qing
    BMC INFECTIOUS DISEASES, 2018, 18
  • [24] Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment
    Zarkotou, O.
    Pournaras, S.
    Tselioti, P.
    Dragoumanos, V.
    Pitiriga, V.
    Ranellou, K.
    Prekates, A.
    Themeli-Digalaki, K.
    Tsakris, A.
    CLINICAL MICROBIOLOGY AND INFECTION, 2011, 17 (12) : 1798 - 1803
  • [25] Risk factors for antibiotic resistance and mortality in patients with bloodstream infection of Escherichia coli
    Zhao, Shunjin
    Wu, Yingjing
    Dai, Zhong
    Chen, Yijing
    Zhou, Xiaojuan
    Zhao, Jun
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2022, 41 (05) : 713 - 721
  • [26] Interspecies differences in clinical characteristics and risk factors for third-generation cephalosporin resistance between Escherichia coli and Klebsiella pneumoniae bloodstream infection in patients with liver cirrhosis
    Ham, Sin Young
    Jung, Hyungul
    Song, Kyoung-Ho
    Jeong, Hyeonju
    Jung, Jongtak
    Moon, Song Mi
    Park, Jeong Su
    Kim, Nak-Hyun
    Jang, Eun Sun
    Kim, Jin-Wook
    Jeong, Sook-Hyang
    Kim, Eu Suk
    Bin Kim, Hong
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2022, 41 (12) : 1459 - 1465
  • [27] Invasive infection caused by Klebsiella pneumoniae is a disease affecting patients with high comorbidity and associated with high long-term mortality
    Vading, M.
    Naucler, P.
    Kalin, M.
    Giske, C. G.
    PLOS ONE, 2018, 13 (04):
  • [28] Risk factors for carbapenem-resistant K. pneumoniae bloodstream infection and predictors of mortality in Chinese paediatric patients
    Zhang, Ye
    Guo, Ling-Yun
    Song, Wen-Qi
    Wang, Yan
    Dong, Fang
    Liu, Gang
    BMC INFECTIOUS DISEASES, 2018, 18
  • [29] Clinical and Microbiologic Analysis of Klebsiella pneumoniae Infection: Hypermucoviscosity, Virulence Factor, Genotype, and Antimicrobial Susceptibility
    Hyun, Miri
    Lee, Ji Yeon
    Kim, Hyun Ah
    DIAGNOSTICS, 2024, 14 (08)
  • [30] A risk score based on pediatric sequential organ failure assessment predicts 90-day mortality in children with Klebsiella pneumoniae bloodstream infection
    Li, Shuang
    Liu, Jingxian
    Chen, Feng
    Cai, Kang
    Tan, Jintong
    Xie, Wei
    Qian, Rong
    Liu, Xiaoqin
    Zhang, Wenhong
    Du, Huimin
    Liu, Ying
    Huang, Lisu
    BMC INFECTIOUS DISEASES, 2020, 20 (01)